The efficacy and tolerability of add-on acarbose therapy in type 2 diabetes mellitus patients inadequately controlled by glibenclamid alone
I. Kinalska, V. Novikov, G. Tamas, S. Czekalski, M. Balabolkin, Z. Szybinski, J. Borawski, M. Stra̧czkowskiVolume:
50
Year:
2000
Language:
english
DOI:
10.1016/s0168-8227(00)81711-8
File:
PDF, 137 KB
english, 2000